OKYO Pharma (OKYO) Loans - Gross (2023 - 2025)
OKYO Pharma (OKYO) posted quarterly Loans - Gross of $422281.0 for Q3 2025, down 77.04% year-over-year from $1.8 million in Q3 2024, and up 74.25% quarter-over-quarter from $242342.0 in Q1 2025.
OKYO Pharma (OKYO) Loans - Gross (2023 - 2025) Analysis & Trends
OKYO Pharma (OKYO) has reported Loans - Gross for 3 consecutive years, with $422281.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Loans - Gross fell 77.04% year-over-year to $422281.0; the TTM figure through Sep 2025 stood at $422281.0 (down 77.04% YoY), while the FY2025 annual figure was $242342.0, up 59.5% from the prior year.
- Loans - Gross advanced to $422281.0 in Q3 2025 per OKYO's latest filing, from $242342.0 in the prior quarter.
- Across five years, Loans - Gross topped out at $1.8 million in Q3 2024 and bottomed at $151938.0 in Q1 2024.
- Historically, Loans - Gross has averaged $591165.6 across 3 years, with a median of $299766.0 in 2023.
- Annual changes were most pronounced in 2024 — Loans - Gross surged 513.65% — and 2025, when it slumped 77.04%.
- OKYO Pharma's Loans - Gross stood at $299766.0 in 2023, then soared by 513.65% to $1.8 million in 2024, then plunged by 77.04% to $422281.0 in 2025.
- Business Quant data shows OKYO's Loans - Gross at $422281.0 in Q3 2025, $242342.0 in Q1 2025, and $1.8 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans - Gross (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | OKYO Pharma | 1.47 Bn | 1.47 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 422,281.00 |
| Mar 31, 2025 | 242,342.00 |
| Sep 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 151,938.00 |
| Sep 30, 2023 | 299,766.00 |